These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7393237)

  • 41. Comparative circular dichroism studies of an anti-fluorescein monoclonal antibody (Mab 4-4-20) and its derivatives.
    Tetin SYu ; Mantulin WW; Denzin LK; Weidner KM; Voss EW
    Biochemistry; 1992 Dec; 31(48):12029-34. PubMed ID: 1457402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate.
    Le Doussal JM; Martin M; Gautherot E; Delaage M; Barbet J
    J Nucl Med; 1989 Aug; 30(8):1358-66. PubMed ID: 2787847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of quenching of fluorescein by anti-fluorescein IgG antibodies.
    Watt RM; Voss EW
    Immunochemistry; 1977 Jul; 14(7):533-51. PubMed ID: 303233
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of secondary forces on the ligand binding properties and variable domain conformations of a monoclonal anti-fluorescyl antibody.
    Mummert ME; Voss EW
    Mol Immunol; 1996 Sep; 33(13):1067-77. PubMed ID: 9010246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The shape of immunoglobulin G molecules in solution.
    Werner TC; Bunting JR; Cathou RE
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):795-9. PubMed ID: 4502932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of bivalent interaction upon apparent antibody affinity: experimental confirmation of theory using fluorescence photobleaching and implications for antibody binding assays.
    Kaufman EN; Jain RK
    Cancer Res; 1992 Aug; 52(15):4157-67. PubMed ID: 1638531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autologous anti-metatype immune response in rabbits.
    Voss EW; Moore JK; Weidner-McGufficke KM; Denzin LK; Bedzyk WD; Voss VH
    Mol Immunol; 1992 Feb; 29(2):241-9. PubMed ID: 1542300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analytical control procedures of immunoreactivity for IgG and Fab fragments specific to haptens.
    Cano NJ; Sabouraud AE; Urtizberea M; Carcagne J; Grandgeorge M; Scherrmann JM
    Pharm Res; 1992 May; 9(5):643-7. PubMed ID: 1608896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoregulation by covalent antigen-antibody complexes. II. Suppression of a T-cell independent anti-hapten response.
    Tite JP; Taylor RB
    Immunology; 1979 Oct; 38(2):325-31. PubMed ID: 315923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the microenvironment of chicken and rabbit antibody active sites.
    Voss EW; Watt RM
    Adv Exp Med Biol; 1977; 88():391-401. PubMed ID: 920520
    [No Abstract]   [Full Text] [Related]  

  • 51. Dissociation kinetics of bivalent ligand-immunoglobulin E aggregates in solution.
    Posner RG; Erickson JW; Holowka D; Baird B; Goldstein B
    Biochemistry; 1991 Mar; 30(9):2348-56. PubMed ID: 1900432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nuclear magnetic resonance and fluorescence studies of the binding of O-carboxymethyl-4-methylumbelliferone to its specific antibody.
    Harina BM; Bothner-By AA; Gill TJ
    Biochemistry; 1977 Oct; 16(20):4504-12. PubMed ID: 562182
    [No Abstract]   [Full Text] [Related]  

  • 53. Characterization of interactions involving anti-metatype antibodies and immune complexes.
    Weidner KM; Voss EW
    Mol Immunol; 1992 Mar; 29(3):303-12. PubMed ID: 1372954
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resolution of rabbit polyclonal anti-fluorescein Fab (IgG) fragments into subpopulations differing in affinity and spectral properties of bound ligand.
    Voss EW; Croney JC; Jameson DM
    Mol Immunol; 2001 Jan; 38(1):35-44. PubMed ID: 11483208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Energy transfer distance measurements in immunoglobulins. II. Localization of the hapten binding sites and the interheavy chain disulfide bond in rabbit antibody.
    Bunting JR; Cathou RE
    J Mol Biol; 1973 Jun; 77(2):223-35. PubMed ID: 4587750
    [No Abstract]   [Full Text] [Related]  

  • 56. Relative binding properties of fluorescein and 9-hydroxyphenylfluoron (HPF) with murine monoclonal anti-fluorescein antibodies.
    Bedzyk WD; Swindlehurst CA; Voss EW
    Biochim Biophys Acta; 1992 Feb; 1119(1):27-34. PubMed ID: 1540631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody-ligand interaction studied by fluorescence enhancement method--IV. Hapten binding activity of peptide fragments from purified antibody heavy chain cleaved by cyanogen bromide.
    Yoo TJ
    Immunochemistry; 1975 Apr; 12(4):317-21. PubMed ID: 811548
    [No Abstract]   [Full Text] [Related]  

  • 58. A hapten-induced conformational change accompanies the cryoprecipitation of an immunoglobulin.
    Okada A; Nakanishi M; Tsurui H; Wada A; Terashima M; Osawa T
    Mol Immunol; 1985 Jun; 22(6):715-8. PubMed ID: 3839565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Equilibrium binding studies on antifluorescein antibody during various stages of the immune response.
    Portmann AJ; Levison SA; Dandliker WB
    Immunochemistry; 1975 Jul; 12(6-7):461-6. PubMed ID: 1184103
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular dynamics of the anti-fluorescein 4-4-20 antigen-binding fragment. 2. Time-resolved fluorescence spectroscopy.
    Lim K; Jameson DM; Gentry CA; Herron JN
    Biochemistry; 1995 May; 34(21):6975-84. PubMed ID: 7766607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.